etoposide has been researched along with Radiation Pneumonitis in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Geng, Y; Hu, Y; Jiang, W; Li, Q; Lu, B; Luo, D; Ma, Z; Ouyang, W; Su, S; Wang, M; Wu, B; Yang, W | 1 |
| Cao, P; Gong, Y; Liang, B; Liu, Y; Lu, Y; Luo, C; Wang, J; Wang, Y; Xu, Y; Xue, J; Yan, T; Zhou, L; Zhou, X; Zhou, Y | 1 |
| Eich, HT; Scobioala, S | 1 |
| Appel, W; Ashcroft, L; Barlesi, F; Bezjak, A; Bhatnagar, A; Blackhall, F; Cardenal, F; Faivre-Finn, C; Fournel, P; Harden, S; Le Pechoux, C; Lorigan, P; McMenemin, R; Mohammed, N; O'Brien, M; Pantarotto, J; Snee, M; Surmont, V; Van Meerbeeck, JP; Woll, PJ | 1 |
| Aggarwal, C; Berman, AT; Cohen, RB; Evans, TL; Langer, C; Levin, WP; Lin, L; Rengan, R; Rwigema, JM; Simone, CB; Verma, V | 1 |
| Cella, L; Conson, M; D'Avino, V; Di Biase, A; Liuzzi, R; Pacelli, R; Picardi, M; Pugliese, N; Salvatore, M; Solla, R | 1 |
| Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J | 1 |
| Bluhme, H; Farr, KP; Grau, C; Kallehauge, JF; Khalil, AA; Kramer, S; Morsing, A; Møller, DS | 1 |
| Bao, Y; Chen, M; Chen, YY; Gao, JM; He, H; Hu, X; Liu, Y; Poudel, S; Sun, ZW; Wang, WH; Wang, Y; Zhang, L; Zhuang, TT | 1 |
| Ji, W; Lü, JM; Ou, GF; Ren, H; Wang, LH; Wang, XZ; Yin, WB; Zhou, ZM | 1 |
| Butler, JB; Cooke, A; Demers, A; Liu, HW; Nugent, Z; Rubinger, M; Schroeder, G; Seftel, MD; Szwajcer, D | 1 |
| Barriger, RB; Fakiris, AJ; Hanna, N; Mantravadi, P; McGarry, RC; Yu, M | 1 |
| Amin, NP; Camidge, DR; Gaspar, LE; Kavanagh, B; Miften, M; Raben, D; Rochford, N; Thornton, D | 1 |
| Palma, DA; Phernambucq, EC; Senan, S; Smit, EF; Vincent, A | 1 |
| Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B | 1 |
| Bi, N; Cao, J; Li, J; Li, W; Liang, J; Lv, J; Ou, G; Ren, H; Wang, L; Wu, S; Zhang, X; Zhou, Z | 1 |
| Barriger, RB; Bradley, JD; De Petris, L; Kim, TH; Marks, LB; Moreno, M; Palma, DA; Ramella, S; Rengan, R; Rodrigues, G; Senan, S; Stitt, L; Tsujino, K | 1 |
| Dong, XJ; Li, LY; Wang, MZ; Xia, Y; Zhang, L; Zhang, XT; Zhao, J; Zhong, W | 1 |
| Ahn, YC; Im, YH; Jung, CW; Kang, WK; Kim, H; Kim, K; Lee, KE; Lee, MH; Lee, SH; Lim, DH; Park, J; Park, K; Park, SH | 1 |
| Allen, PK; Blumenschein, GR; Cox, JD; Fossella, FV; Garza, VP; Glisson, BS; Herbst, RS; Kaplan, B; Kies, MS; Komaki, R; Kurie, J; Lee, HK; Lee, JS; Liao, Z; Lu, C; Milas, L; Mooring, D; Papadimitrakopoulou, VA; Pisters, KM; Stevens, CW; Tucker, SL; Zinner, RG | 1 |
| Arnaiz Fernández, MD; Cardenal Alemany, F; Guedea Edo, F; Jeremic, B; Lucas Calduch, A; Montes Borinaga, A; Navarro Pérez, V; San José Maderuelo, S; Serrano Bermúdez, G | 1 |
| Gospodarowicz, MK; Heaton, R; Hodgson, DC; Koh, ES; Pintilie, M; Sun, A; Tran, TH; Tsang, R; Wells, W | 1 |
| Creagan, ET; Eagan, RT; Foote, RL; Frytak, S; Jett, JR; Richardson, RL; Shaw, EG; Su, JQ | 1 |
| Araki, T; Hara, R; Hatano, K; Imai, Y; Ogata, H; Ohnishi, H; Okada, J; Takizawa, Y; Yamaguchi, M | 1 |
| Coy, P; Feld, R; Murray, N; Pater, J; Payne, DG; Quon, H; Sadura, A; Shepherd, FA; Zee, B | 1 |
| Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
| Abraham, R; Chen, CI; Crump, M; Keating, A; Stewart, AK; Tsang, R | 1 |
| Allen, P; Cox, JD; Fossella, FV; Glisson, B; Herbst, R; Hong, WK; Kaplan, B; Kelly, JF; Khuri, F; Komaki, R; Kurie, J; Lee, JS; Liao, Z; Milas, L; Papadimitrakopoulou, V; Pisters, K; Ro, J; Stevens, CW; Thames, HD; Zinner, R | 1 |
2 review(s) available for etoposide and Radiation Pneumonitis
| Article | Year |
|---|---|
Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Combined Modality Therapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Melphalan; Procedures and Techniques Utilization; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Respiratory Function Tests; Risk; Sarcoma, Ewing; Whole-Body Irradiation; Young Adult | 2020 |
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Decision Trees; Etoposide; Europe; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; North America; Paclitaxel; Radiation Pneumonitis; Radiotherapy Dosage | 2013 |
9 trial(s) available for etoposide and Radiation Pneumonitis
| Article | Year |
|---|---|
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophagitis; Etoposide; Humans; Lung Neoplasms; Radiation Pneumonitis; Small Cell Lung Carcinoma | 2023 |
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Small Cell Lung Carcinoma; Survival Rate | 2017 |
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Etoposide; Humans; Lung; Lung Neoplasms; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Taxoids; Tumor Burden | 2010 |
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Radiation Pneumonitis; Treatment Outcome | 2012 |
A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2003 |
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Confidence Intervals; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Pneumonitis; Radiation-Protective Agents; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 2004 |
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Remission Induction; Survival Rate; Thrombocytopenia | 1996 |
[Effect of daily administration of oral etoposide for non-small cell lung cancer treated with concurrent radiation therapy].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Pneumonitis; Survival Rate; Treatment Outcome | 1997 |
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Topics: Adult; Aged; Amifostine; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents | 2002 |
17 other study(ies) available for etoposide and Radiation Pneumonitis
| Article | Year |
|---|---|
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Intensity-Modulated; Respiratory Function Tests; Retrospective Studies; Risk; ROC Curve; Sensitivity and Specificity; Severity of Illness Index | 2020 |
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dose Fractionation, Radiation; Esophagitis; Esophagus; Etoposide; Female; Heart; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Organs at Risk; Prospective Studies; Proton Therapy; Radiation Pneumonitis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma; Spinal Cord; Treatment Outcome | 2017 |
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Lung Injury; Middle Aged; Prednisone; Radiation Pneumonitis; Retrospective Studies; ROC Curve; Vinblastine; Young Adult | 2014 |
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome | 2015 |
Inclusion of functional information from perfusion SPECT improves predictive value of dose-volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Dose-Response Relationship, Radiation; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation Pneumonitis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
[Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Esophagitis; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, High-Energy; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2008 |
[Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Survival Rate; Topotecan | 2009 |
Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose Fractionation, Radiation; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Manitoba; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiation Pneumonitis; Retrospective Studies; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation; Young Adult | 2010 |
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Risk Assessment; Small Cell Lung Carcinoma; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 2011 |
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult | 2012 |
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate | 2012 |
[Combined radiochemotherapy in localised small-cell lung cancer. Concurrent treatment protocols?].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Esophagitis; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome | 2005 |
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Lung; Male; Mediastinum; Middle Aged; Prednisone; Procarbazine; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vinblastine; Vincristine | 2006 |
The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Patient Compliance; Radiation Pneumonitis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Vincristine | 1999 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Prognosis; Radiation Pneumonitis; Retrospective Studies; Transplantation, Autologous; Whole-Body Irradiation | 2001 |